Drug Side Effects
Search
NEUROENDOCRINE CARCINOMA OF THE CERVIX
NEUROENDOCRINE CARCINOMA OF THE CERVIX
was reported 15 times
These drug classes are most commonly taken by patients reporting NEUROENDOCRINE CARCINOMA OF THE CERVIX:
#
Drug
Count
0
Vascular Endothelial Growth Factor Inhibitor [EPC]
7
1
Topoisomerase Inhibitor [EPC]
6
2
Microtubule Inhibitor [EPC]
5
3
Programmed Death Receptor-1 Blocking Antibody [EPC]
4
4
CTLA-4-directed Blocking Antibody [EPC]
3
5
Platinum-based Drug [EPC]
3
6
Kinase Inhibitor [EPC]
2
7
Programmed Death Ligand-1 Blocker [EPC]
2
8
mTOR Inhibitor Immunosuppressant [EPC]
2
9
CD20-directed Cytolytic Antibody [EPC]
1
10
Corticosteroid [EPC]
1
11
Human Immunoglobulin G [EPC]
1
12
Leukocyte Growth Factor [EPC]
1